Journal articles and review articles in CC journals (12) Other papers in CC journals (1) Scientific papers in other journals (2) Nonscientific papers in other journals (2) Conference reports (abstracts) in CC journals (3) Plenary/Keynote talks (1) Abstracts in Book of abstracts (6)   Printer version
	Journal articles and review articles in CC journals
	1. Ahel, Zaky; Kovačić, Ksenija; Kraljić, Ivo; Tarle, Marko. Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients.. // Anticancer Research. 21 (2001) ; 1475-1480 (journal article). 2. Ahel, Zaky; Kovačić, Ksenija; Tarle, Marko. Cross-correlation of serum Chromogranin A, %F-PSA and bone scans in prostate cancer diagnosis.. // Anticancer Research. 21(2B) (2001) ; 1363-1366 (journal article). 3. Tarle, Marko. Serum chromogranin A level vs. false negative F/TPSA data in prostate cancer diagnosis. // European Urology. 38 (2000) , 4; 505-505 (journal article). 4. Tarle, Marko. Serum Chromogranin A in metastatic prostate cancer patients. // Anticancer Research. 16 (1999) , 6; 5663-5666 (journal article). 5. Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Tarle, Robert; Kaštelan, Maja. T-PSA, NK activity and TPS value during prostate cancer progression and in responders to therapy.. // Journal of tumor marker oncology. 13 (1998) , 2; 33-33 (journal article). 6. Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, Ante. Serum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and a probe used in staging protocols.. // Anticancer research. 18 (1998) , 6c; 4957-4957 (journal article). 7. Tarle, Marko; Kraljić, Ivo; Ružić, Boris; Anzulović, Zdravko; Trnski, Davor; Katušić, Josip; Reljić, Ante; Kovačić, Ksenija. Conversion of hormone sensitive prostate cancer to hormone resistant disease: A subclinical detection.. // Anticancer research. 18 (1998) , 6c; 4958-4959 (journal article). 8. Tarle, Marko; Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Kovačić, Ksenija. Percent free PSA (%F-PSA) value in follow-up treatment of hormone sensitive prostate cancer. %F-PSA as a succeful prognosticator to hormone therapy.. // Anticancer research. 18 (1998) , 6c; 4958 (journal article). 9. Tarle, Marko; Reljić, Ante; Kraus, Ognjen; Kraljić, Ivo; Ruži, Boris; Trnski, Davor. A novel procedure for the detection of prostate cancer in situ by applying Finasteride therapy.. // Anticancer research. 18 (1998) , 6c; 4959-4959 (journal article). 10. Kaštelan, Marija; Kovačić, Ksenija; Tarle, Robert; Kraljić, Ivo; Tarle, Marko. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer. // Anticancer research. 17 (1997) , 3B; 1671-1676 (journal article). 11. Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Tarle, Marko. Introduction into the use of serum F/T%PSA value in distinguishing between BPH, latent and manifest prostatic adenocarcinoma. // British journal of urology. 80 (1997) , suppl. 2; 246-246 (journal article). 12. Tarle, Marko; Kraljić, Ivo. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH : is F/T PSA a potential probe for dormant and manifest cancer?. // Anticancer research. 17 (1997) , 3A; 1531-1534 (journal article).
	Other papers in CC journals
	1. Kraljić, Ivo; Katušić, Josip; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Ružić, Boris; Tarle, Marko. The use of free and total serum PSA values (F/T%PSA) in discriminating BPH from latent, manifest and "manifest-to-be" prostatic carcinoma. // Journal of tumor marker oncology. 12 (1997) , 4; 57-58.
	Scientific papers in other journals
	1. Tarle, Marko. Analysis of TPS application in prostate cancer : a critical commentary. // Journal of tumor marker oncology. 12 (1997) , 2; 74-74 (journal article). 2. Tarle, Marko; Kraljić, Ivo. Serum free/total percent PSA value as a clinical tool for discriminating latent from manifest prostatic carcinoma. // Acta clinica Croatica. 36 (1997) , 1; 15-20 (journal article).
	Nonscientific papers in other journals
	1. Kovačić, Ksenija; Tarle, Marko; Kusić, Zvonko. The role of bone scanning in the diagnosis and monitoring of patients with prostatic cancer. // Acta clinica Croatica. 37 (1998) , 3; 265-267. 2. Ružić, Boris; Reljić, Ante; Trnski, Davor; Kraus, Ognjen; Anzulović, Zdravko; Katušić, Josip; Tarle, Marko. Multivariate analysis of serum tumor markers in prostate cancer patients treated with triptorelin and maximal androgen blockade. // Acta clinica Croatica. 36 (1997) , 1; 41-48 (journal article).
	Conference reports (abstracts) in CC journals
	1. Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, Ante. Serum TPS and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy // From Tumor Biology to Clinical Oncology (Tumor Biology, Vol. 19, Suppl. 2, 1998). 1998. 21-21 (poster,abstract,scientific). 2. Tarle, Marko; Kraus, Ognjen; Kraljić, Ivo; Trnski, Davor; Anzulović, Zdravko; Katušić, Josip; Reljić, Ante; Ružić, Boris. Subclinical distinction of symptomatic BPH from prostate cancer in Finasteride treated patients. // Journal of Tumor Marker Oncology. 13(2), 1998 Sum.. 1998. 32-33 (poster,abstract,scientific). 3. Tarle, Marko; Kraljić, Ivo. F/T%PSA values in patients with prostatic disorders and T-PSA ranging 3-15 ng/ml : introduction into the use in screening protocols // Tumor Biology, Suppl 2 (From Basic Cancer Research to Clinical Application). 1997. 29-29 (poster,abstract,scientific).
	Plenary/Keynote talks
	1. Tarle, Marko. Neuroendocrine structures in prostate cancer patients. // Anticancer Research / Delinassios, John, editor(s). Athens, Greece : International Institute for Anticancer Research, 2001. 1659-1660 (plenary/keynote lecture,international peer-review,abstract,scientific).
	Abstracts in Book of abstracts
	1. Ahel, Zaky; Kovačić, Ksenija; Kraljić, Ivo; Trnski, Davor; Tarle, Marko. Estramustine therapy in Chromogranin A-positive Prostate Cancer Patients. // Proceedings, 11th International Prostate Cancer Update / Crawford, E David, editor(s). Denver : Medical Education Collaborative, 2001. 331-331 (lecture,international peer-review,abstract,scientific). 2. Ahel, Zaky; Kraljić, Ivo; Kovačić, Ksenija; Tarle, Marko. Impact of neuroendocrine differentiation on false positive %FPSA findings and bone metastases in newly diagnosed prostate cancer patients. // Proceedings, 11th International Prostate Cancer Update / Crawford, David, editor(s). Denver : Medical Education Collaborative, 2001. 278-278 (lecture,international peer-review,abstract,scientific). 3. Tarle, Marko; Ahel, Zaky; Kovačić, Ksenija. Neuroendocrine differentiation and androgen deficient environment in prostate cancer patients. // Anticancer Research / Delinassios, John, editor(s). Athens, Greece : International Institute for Anticancer Research, 2001. 1660-1660 (lecture,international peer-review,abstract,scientific). 4. Tarle, Marko; Trnski, Davor; Ružić, Boris; Spajić, Boro; Reljić, Ante; Anzulović, Zdravko; Katušić, Josip; Kraus, Ognjen; Ahel, Zaky; Kraljić, Ivo. Neuroendocrine differentiation in subclinically detected prostate cancer and during a subsequent disease progression. // Anticancer Research / Delinassios, John, editor(s). Athens, Greece : International Institute for Anticancer Research, 2001. 1660-1661 (lecture,international peer-review,abstract,scientific). 5. Tarle, Marko. Subclinical diagnosis and monitoring of prostate cancer patients. // Suvremeni pristupi u dijagnostici i liječenju raka prostate. / Šamija, Mirko., editor(s). Zagreb : Klinika za tumore, Zagreb, 1998. 12-12 (invited talk,domestic peer-review,abstract). 6. Tarle, Marko; Reljić, Ante; Spajić, Boris; Ružić, Boris; Trnski, Davor; Kraus, Ognjen; Kraljić, Ivo. Is Finasteride therapy of BPH a route to the early detection of prostate cancer in situ? // Drugi hrvatski urološki kongres / Peterković, Vjerislav., editor(s). Rijeka : Hrvatsko urološko društvo, 1998. 71-71 (lecture,abstract,scientific).